CIK: 0001802528 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 12, 2021
Total Value ($000): $279,600 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 961,797 | $32,018 | 11.5% | $20.81 | +75.6% | COM PAR $.01 | 457669307 |
| FOLD | AMICUS THERAPEUTICS INC | 1,315,395 | $30,372 | 10.9% | $9.80 | +108.7% | COM | 03152W109 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 565,890 | $26,257 | 9.4% | $24.87 | +59.7% | COM | 462260100 |
| ACAD | ACADIA PHARMACEUTICALS INC | 450,317 | $24,074 | 8.6% | $43.17 | +15.0% | COM | 004225108 |
| — | TRILLIUM THERAPEUTICS INC | 1,478,181 | $21,744 | 7.8% | $4.53 | — | COM NEW | 89620X506 |
| — | ALLAKOS INC | 147,662 | $20,673 | 7.4% | $81.12 | — | COM | 01671P100 |
| — | ZOGENIX INC | 980,645 | $19,603 | 7.0% | $36.29 | — | COM NEW | 98978L204 |
| AXSM | AXSOME THERAPEUTICS INC | 220,098 | $17,931 | 6.4% | $80.87 | -7.5% | COM | 05464T104 |
| COGT | COGENT BIOSCIENCES INC | 1,558,975 | $17,507 | 6.3% | $10.99 | 0.0% | COM | 19240Q201 |
| ARGX | ARGENX SE | 49,950 | $14,690 | 5.3% | $160.52 | — | SPONSORED ADR | 04016X101 |
| — | MIRATI THERAPEUTICS INC | 60,500 | $13,288 | 4.8% | $188.64 | — | COM | 60468T105 |
| — | KARYOPHARM THERAPEUTICS INC | 702,351 | $10,872 | 3.9% | $18.82 | — | COM | 48576U106 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 215,000 | $9,312 | 3.3% | $43.31 | — | COM | 37890U108 |
| — | AMARIN CORP PLC | 1,508,237 | $7,375 | 2.6% | $14.78 | — | SPONS ADR NEW | 023111206 |
| ENTA | ENANTA PHARMACEUTICALS INC | 150,433 | $6,333 | 2.3% | $61.59 | -28.6% | COM | 29251M106 |
| — | SERES THERAPEUTICS INC | 257,016 | $6,297 | 2.3% | $24.50 | — | COM | 81750R102 |
| — | VERONA PHARMA PLC | 100,000 | $700 | 0.3% | $6.24 | — | SPONSORED ADS | 925050106 |
| — | MIRAGEN THERAPEUTICS INC | 35,092 | $554 | 0.2% | $15.79 | — | COM NEW | 60463E202 |